Test Research, Inc.(TW:3030)
NT$233.50+8.00 (+3.55%)
TW:3030
Test Research, Inc. financials statements
NT$233.50
At close:+8.00 (+3.55%)
Test Research, Inc. (3030) Ratios
Test Research, Inc. Ratios
TW:3030's free cash flow for Q2 2026 was NT$452.90M. For the 2026 fiscal year, TW:3030's free cash flow was decreased by NT$-21.60M and operating cash flow was NT$474.50M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.45 | 3.74 | 3.44 | 3.75 | 3.52 |
| Quick Ratio | 2.63 | 2.86 | 2.57 | 2.83 | 2.43 |
| Cash Ratio | 0.58 | 0.55 | 0.59 | 0.72 | 0.77 |
| Solvency Ratio | 1.05 | 1.09 | 0.67 | 1.08 | 0.69 |
| Operating Cash Flow Ratio | 0.77 | 0.73 | 1.30 | 0.92 | 0.37 |
| Short-Term Operating Cash Flow Coverage | 67.39 | 68.19 | 104.00 | 85.44 | 19.40 |
| Net Current Asset Value | NT$ 5.18B | NT$ 4.08B | NT$ 3.27B | NT$ 4.09B | NT$ 3.69B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.27 | 1.22 | 1.24 | 1.26 | 1.31 |
| Debt Service Coverage Ratio | 95.51 | 102.86 | 55.16 | 105.84 | 41.33 |
| Interest Coverage Ratio | 1213.40 | 719.15 | 439.88 | 1054.89 | 1005.50 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.30 | 0.21 | 0.29 | 0.27 | 0.38 |
| Net Debt to EBITDA | -0.38 | -0.35 | -0.57 | -0.42 | -0.67 |
| Profitability Margins | |||||
| Gross Profit Margin | 58.35% | 59.54% | 59.31% | 57.37% | 54.36% |
| EBIT Margin | 35.34% | 34.51% | 28.36% | 36.61% | 27.81% |
| EBITDA Margin | 37.67% | 37.47% | 31.60% | 38.71% | 30.26% |
| Operating Profit Margin | 35.34% | 32.03% | 27.25% | 36.70% | 27.76% |
| Pretax Profit Margin | 35.39% | 34.26% | 28.30% | 36.58% | 27.78% |
| Net Profit Margin | 29.27% | 28.90% | 22.58% | 28.64% | 21.14% |
| Continuous Operations Profit Margin | 29.27% | 28.90% | 22.58% | 28.64% | 21.14% |
| Net Income Per EBT | 82.72% | 84.34% | 79.77% | 78.30% | 76.09% |
| EBT Per EBIT | 100.14% | 106.97% | 103.88% | 99.66% | 100.06% |
| Return on Assets (ROA) | 20.39% | 18.11% | 11.24% | 20.95% | 14.79% |
| Return on Equity (ROE) | 25.81% | 22.18% | 13.93% | 26.44% | 19.44% |
| Return on Capital Employed (ROCE) | 30.18% | 23.80% | 16.20% | 32.51% | 24.25% |
| Return on Invested Capital (ROIC) | 24.85% | 19.99% | 12.84% | 25.34% | 18.29% |
| Return on Tangible Assets | 20.43% | 18.16% | 11.28% | 21.00% | 14.84% |
| Earnings Yield | 5.48% | 6.37% | 6.77% | 12.77% | 8.58% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.97 | 2.00 | 1.92 | 2.22 | 2.37 |
| Payables Turnover | 3.17 | 3.80 | 3.55 | 5.92 | 2.79 |
| Inventory Turnover | 1.92 | 1.83 | 1.43 | 1.95 | 1.46 |
| Fixed Asset Turnover | 2.00 | 1.58 | 1.17 | 2.19 | 2.45 |
| Asset Turnover | 0.70 | 0.63 | 0.50 | 0.73 | 0.70 |
| Working Capital Turnover Ratio | 1.72 | 1.61 | 1.12 | 1.59 | 1.45 |
| Cash Conversion Cycle | 259.57 | 286.19 | 341.99 | 290.09 | 272.78 |
| Days of Sales Outstanding | 184.87 | 182.41 | 189.75 | 164.71 | 154.31 |
| Days of Inventory Outstanding | 189.83 | 199.72 | 255.19 | 187.02 | 249.19 |
| Days of Payables Outstanding | 115.13 | 95.94 | 102.95 | 61.63 | 130.72 |
| Operating Cycle | 374.70 | 382.14 | 444.94 | 351.73 | 403.50 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 7.27 | 4.91 | 7.95 | 6.21 | 2.50 |
| Free Cash Flow Per Share | 6.06 | 3.26 | 4.24 | 3.33 | 1.85 |
| Dividend Paid and CapEx Coverage Ratio | 1.17 | 0.99 | 0.97 | 1.01 | 0.63 |
| Capital Expenditure Coverage Ratio | 6.00 | 2.98 | 2.14 | 2.16 | 3.81 |
| Operating Cash Flow Coverage Ratio | 25.21 | 24.83 | 28.16 | 23.53 | 6.78 |
| Operating Cash Flow to Sales Ratio | 0.20 | 0.18 | 0.42 | 0.22 | 0.11 |
| Free Cash Flow Yield | 3.17% | 2.67% | 6.77% | 5.23% | 3.16% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 18.26 | 15.72 | 14.76 | 7.84 | 11.65 |
| Price-to-Sales (P/S) Ratio | 5.34 | 4.53 | 3.33 | 2.24 | 2.46 |
| Price-to-Book (P/B) Ratio | 4.71 | 3.48 | 2.06 | 2.07 | 2.27 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 31.59 | 37.40 | 14.77 | 19.11 | 31.67 |
| Price-to-Operating Cash Flow Ratio | 26.32 | 24.85 | 7.87 | 10.26 | 23.37 |
| Price-to-Earnings Growth (PEG) Ratio | 0.52 | 0.19 | -0.31 | 0.13 | 1.38 |
| Enterprise Value Multiple | 13.80 | 11.75 | 9.98 | 5.38 | 7.47 |
| Enterprise Value | 44.03B | 27.99B | 13.99B | 13.96B | 12.68B |
| EV to EBITDA | 13.80 | 11.75 | 9.98 | 5.38 | 7.47 |
| EV to Sales | 5.20 | 4.40 | 3.15 | 2.08 | 2.26 |
| EV to Free Cash Flow | 30.74 | 36.32 | 13.97 | 17.73 | 29.06 |
| EV to Operating Cash Flow | 25.61 | 24.14 | 7.45 | 9.52 | 21.44 |
| Tangible Book Value Per Share | 40.55 | 34.94 | 30.31 | 30.66 | 25.69 |
| Shareholders’ Equity Per Share | 40.64 | 35.06 | 30.43 | 30.76 | 25.81 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.17 | 0.16 | 0.20 | 0.22 | 0.24 |
| Revenue Per Share | 35.83 | 26.91 | 18.78 | 28.40 | 23.74 |
| Net Income Per Share | 10.49 | 7.78 | 4.24 | 8.13 | 5.02 |
| Tax Burden | 0.83 | 0.84 | 0.80 | 0.78 | 0.76 |
| Interest Burden | 1.00 | 0.99 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.08 | 0.09 | 0.10 | 0.08 | 0.09 |
| SG&A to Revenue | 0.15 | 0.18 | 0.22 | 0.17 | 0.18 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.69 | 0.53 | 1.50 | 0.60 | 0.38 |
Currency in TWD
